Validation of ketamine as a pharmacological model of thalamic dysconnectivity across the illness course of schizophrenia

Samantha V. Abram, Brian J. Roach, Susanna L. Fryer, Vince D. Calhoun, Adrian Preda, Theo G.M. van Erp, Juan R. Bustillo, Kelvin O. Lim, Rachel L. Loewy, Barbara K. Stuart, John H. Krystal, Judith M. Ford, Daniel H. Mathalon

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Validation of ketamine as a pharmacological model of thalamic dysconnectivity across the illness course of schizophrenia'. Together they form a unique fingerprint.

Medicine & Life Sciences